Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune‐mediated trhrombotic thrombocytopenic purpura
Open Access
- 17 February 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 189 (1), e18-e20
- https://doi.org/10.1111/bjh.16415
Abstract
No abstract availableFunding Information
- Alexion Pharmaceuticals
This publication has 8 references indexed in Scilit:
- Ultralarge Von Willebrand Factor–Induced Platelet Clumping and Activation of the Alternative Complement Pathway in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic SyndromesHematology/Oncology Clinics of North America, 2015
- von Willebrand factor is a cofactor in complement regulationBlood, 2015
- Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpuraJournal of Thrombosis and Haemostasis, 2013
- Complement activation in thrombotic thrombocytopenic purpuraJournal of Thrombosis and Haemostasis, 2012
- Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapseBritish Journal of Haematology, 2008
- ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remissionHaematologica, 2008
- Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activityBlood, 2006
- Regression Shrinkage and Selection Via the LassoJournal of the Royal Statistical Society: Series B (Methodological), 1996